| ISIN | CH0265300084 |
|---|---|
| Valor Number | 26530008 |
| Bloomberg Global ID | CCSEUBC SW |
| Fund Name | CS Fund 3 - Credit Suisse (CH) 130/30 Swiss Equity Fund UB CHF |
| Fund Provider |
UBS AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | A feature of the umbrella fund’s Subfund is that the fund management company may – in accordance with the respective investment policy focusing on particular countries or regions – increase the proportion of money invested to a maximum of 125% of a subfund’s net assets (leverage effect) by using derivatives and/or by taking out loans. The investment objective of this Subfund is primarily to achieve an appropriate return in the accounting currency by investing in the instruments listed below. Due account shall be taken of the principle of risk diversification, security of the capital invested and liquidity of the fund’s assets. This Subfund invests primarily in equities and equity-type securities (shares, dividendright certificates, shares in cooperatives, participation certificates, etc.) of companies domiciled in or carrying out the bulk of their business activities in Switzerland, and in other investments permitted under the fund contract. |
| Peculiarities |
| Current Price * | 22.05 CHF | 02.12.2025 |
|---|---|---|
| Previous Price * | 21.97 CHF | 01.12.2025 |
| 52 Week High * | 22.33 CHF | 07.03.2025 |
| 52 Week Low * | 18.99 CHF | 09.04.2025 |
| NAV * | 22.05 CHF | 02.12.2025 |
| Issue Price * | 22.03 CHF | 02.12.2025 |
| Redemption Price * | 22.03 CHF | 02.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 257,573,187 | |
| Unit/Share Assets *** | 40,687,591 | |
| Trading Information SIX | ||
| YTD Performance | +11.59% |
31.12.2024 - 02.12.2025
31.12.2024 02.12.2025 |
|---|---|---|
| 1 month | +4.80% |
03.11.2025 - 02.12.2025
03.11.2025 02.12.2025 |
| 3 months | +5.60% |
02.09.2025 - 02.12.2025
02.09.2025 02.12.2025 |
| 6 months | +2.94% |
02.06.2025 - 02.12.2025
02.06.2025 02.12.2025 |
| 1 year | +10.03% |
02.12.2024 - 02.12.2025
02.12.2024 02.12.2025 |
| 2 years | +14.19% |
04.12.2023 - 02.12.2025
04.12.2023 02.12.2025 |
| 3 years | +16.61% |
02.12.2022 - 02.12.2025
02.12.2022 02.12.2025 |
| 5 years | +28.20% |
02.12.2020 - 02.12.2025
02.12.2020 02.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 15.20% | |
|---|---|---|
| Nestle SA | 14.52% | |
| Novartis AG Registered Shares | 11.37% | |
| UBS Group AG Registered Shares | 7.53% | |
| Zurich Insurance Group AG | 6.24% | |
| ABB Ltd | 5.55% | |
| Compagnie Financiere Richemont SA Class A | 4.33% | |
| Lonza Group Ltd | 4.20% | |
| Swiss Re AG | 4.10% | |
| Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting | 3.88% | |
| Last data update | 31.10.2025 | |
| TER | 0.77% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | 0.77% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |